Myocardial Hypertrophy Resulting from Low Dosage Isoproterenol Administration in Rats
E. L. Alderman(Stanford University), David Harrison(Chelmsford and Essex Hospital)
Cited by 49
Related Papers
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
|Journal of Medicinal Chemistry|2023|62
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
|European Journal of Pharmacology|2014|54
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796
|Journal of Pharmacology and Experimental Therapeutics|2024|51
Engineering transglycosidase activity into a GH51 α-l-arabinofuranosidase
|New Biotechnology|2013|35
1,2,4-Triazolo-[1,5-<i>a</i>]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction
|Journal of Medicinal Chemistry|2017|34